seekingalpha.com
/1 month ago
Latest updates for Cvrx
Fresh curated links around CVRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- CVRx, Inc. (CVRX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow
- Corvus Pharmaceuticals, Inc. (CRVS) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
- Biggest stock movers Tuesday: CRNX, RIVN, and more
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
Corvus Pharmaceuticals, Inc. (CRVS) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
fool.com
/1 month ago
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding
Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.
newswire.com
/2 days ago
OSR Health, A Message From the CEO
Read the CEO’s letter outlining OSR Health’s proposed Shareholder Loyalty CVR Program, VXM01 progress, Woori IO and the company’s long-term strategy
fool.com
/1 month ago
CorVel (CRVL) Q4 2026 Earnings Call Transcript
Image source: The Motley Fool. DATEWednesday, May 20, 2026 at 11:30 a.m. ETCALL PARTICIPANTSPresident & CEO — Michael CombsChief Financial Officer — Brian Nichols[Role Unspeci...
fool.com
/1 month ago
CorVel (CRVL) Q4 2026 Earnings Call Transcript
Image source: The Motley Fool. DATEWednesday, May 20, 2026 at 11:30 a.m. ETCALL PARTICIPANTSPresident & CEO — Michael CombsChief Financial Officer — Brian Nichols[Role Unspeci...
fool.com
/1 month ago
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.
seekingalpha.com
/1 month ago
Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential
cafepharma.com
/1 month ago
The CVRM quiet mass exodus
The CVRM quiet mass exodus Anonymous (not verified) Thu, 06/11/2026 - 20:51 field_thread_url https://cafepharma.com/boards/threads/the-cvrm-quiet-mass-exod...
seekingalpha.com
/2 weeks ago
Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow
orthotw.com
/1 month ago
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXUâ„¢ Wound Care Program
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission
cafepharma.com
/1 month ago
The CVRM quiet mass exodus
The CVRM quiet mass exodus Anonymous (not verified) Tue, 06/09/2026 - 17:50 field_thread_url https://cafepharma.com/boards/threads/the-cvrm-quiet-mass-exod...
cafepharma.com
/3 weeks ago
CV cuts
CV cuts Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/cv-cuts.717190/ board na...
seekingalpha.com
/1 month ago
Corebridge Financial, Inc. (CRBG) Presents at Morgan Stanley US Financials Conference 2026 Transcript
seekingalpha.com
/1 month ago
Revolution Medicines, Inc. (RVMD) Discusses Positive Clinical Results and Implications for Metastatic Pancreatic Cancer...
seekingalpha.com
/1 month ago
Viridien Société anonyme (VIRDY) Shareholder/Analyst Call Transcript
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Cvrx
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
ryortho.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source